BiotechTube
Home/Schrodinger/Jaren Madden
JM

Jaren Madden

Chief Corporate Affairs Officer and Head of Investor Relations

Schrodinger

Therapeutic Areas

Oncology

Schrodinger Pipeline

DrugIndicationPhase
MALT1 InhibitorOncology (Lymphomas)Phase 1
CDC7 InhibitorOncology (Solid Tumors)Preclinical
SOS1::KRAS InhibitorOncology (KRAS-driven cancers)Discovery/Preclinical
Wee1 InhibitorOncologyPreclinical

Leadership Team at Schrodinger

RF
Ramy Farid, Ph.D.
President and CEO, Board Member
RA
Robert Abel, Ph.D.
Executive Vice President, Chief Scientific Officer, Platform
KA
Karen Akinsanya, Ph.D.
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
MA
Mannix Aklian
Executive Vice President, Chief Commercial Officer, Global Head of Software Sales and Marketing
RJ
Richie Jain
Chief Financial Officer
PL
Patrick Lorton
Executive Vice President, Chief Technology Officer and Chief Operating Officer, Software
ML
Michael Lynton
Chairman of the Board
RA
Richard A. Friesner
Co-founder, Board Member, and Scientific Advisory Chairman
View full Schrodinger profile